A Phase 2 Study of the Effect of Microneedle Lesion Preparation, Incubation Time and Light Power Density on Photodynamic Therapy With Levulan Kerastick (Aminolevulinic Acid HCl) for Topical Solution, 20% + Blue Light for the Field Treatment of Actinic Keratoses on the Face
Phase of Trial: Phase II
Latest Information Update: 10 Feb 2017
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- Sponsors DUSA Pharmaceuticals
- 07 Feb 2017 Status changed from active, no longer recruiting to completed.
- 22 Sep 2016 Planned End Date changed from 1 Sep 2016 to 1 Nov 2016.
- 22 Sep 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Sep 2016.